Pather, US
Indiran Pather, Rancho Cordova, CA US
Patent application number | Description | Published |
---|---|---|
20100266682 | POLYETHYLENE GLYCOL-COATED SODIUM CARBONATE AS A PHARMACEUTICAL EXCIPIENT AND COMPOSITIONS PRODUCED FROM THE SAME - Non-effervescent pharmaceutical compositions having at least one particle of carbonate coated by a layer of polyethylene glycol that substantially covers the at least one carbonate particle are described. Compositions are also described where the compositions include a weakly basic therapeutic agent, a first pH-modifying agent having at least one particle of carbonate coated by a layer of polyethylene glycol, and a second pH-modifying agent. The weakly basic therapeutic agent could be, but is not limited to, zolpidem or scopolamine. Compositions including zolpidem and scopolamine are used to treat insomnia and depression, respectively. | 10-21-2010 |
20130122099 | POLYETHYLENE GLYCOL-COATED SODIUM CARBONATE AS A PHARMACEUTICAL EXCIPIENT AND COMPOSITIONS PRODUCED FROM THE SAME - Non-effervescent pharmaceutical compositions having at least one particle of carbonate coated by a layer of polyethylene glycol that substantially covers the at least one carbonate particle are described. Compositions are also described where the compositions include a weakly basic therapeutic agent, a first pH-modifying agent having at least one particle of carbonate coated by a layer of polyethylene glycol, and a second pH-modifying agent. The weakly basic therapeutic agent could be, but is not limited to, zolpidem or scopolamine. Compositions including zolpidem and scopolamine are used to treat insomnia and depression, respectively. | 05-16-2013 |
20140056828 | NOVEL FORMULATIONS AND USES FOR CURCUMA EXTRACTS - Formulations and uses of extracts of | 02-27-2014 |
20140056829 | SUNSCREEN COMPRISING A CURCUMA EXTRACT - Sunscreen compositions containing an extract of | 02-27-2014 |
20140056830 | METHOD OF PRODUCING A SAFE, WHOLE-EXTRACT OF CURCUMA FOR ORAL AND TOPICAL USE - Methods of making safe extracts of | 02-27-2014 |
Sathasivan I. Pather, El Sobrante, CA US
Patent application number | Description | Published |
---|---|---|
20100249177 | COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE-NIGHT INSOMNIA - The present invention provides compositions for treating middle-of-the-night insomnia without residual sedative effects upon awakening by administering low doses (about 5 mg or less) of zolpidem or a salt thereof. | 09-30-2010 |
20110039881 | COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE-NIGHT INSOMNIA - The present invention provides compositions and methods for treating middle-of-the-night insomnia without residual sedative effects upon awakening by dosing an amount of zolpidem or a salt thereof to a subject who awakens from sleep and desires to resume sleep for less than 5 hours. The step of dosing is performed after the subject awakens from sleep and the amount permits the subject to awaken at a time about four hours after dosing without residual sedative effects. | 02-17-2011 |
20130210856 | COMPOSITIONS AND METHODS FOR TREATING SLEEP DISORDERS - The present invention provides liquid dosage forms for treating narcolepsy. The liquid dosage form includes zolpidem or a pharmaceutically acceptable salt thereof, a carbonate salt, a metal oxide, and a borate salt. The present invention also provides methods for treating somnambulism. The methods include administering an emulsion that includes zolpidem, a bicarbonate salt, a citrate salt, and a phosphate salt. | 08-15-2013 |
Sathasivan I. Pather, Rancho Cordova, CA US
Patent application number | Description | Published |
---|---|---|
20150352084 | COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE-NIGHT INSOMNIA - The present invention provides liquid dosage forms for treating narcolepsy. The liquid dosage form includes zolpidem or a pharmaceutically acceptable salt thereof, a carbonate salt, a metal oxide, and a borate salt. The present invention also provides methods for treating somnambulism. The methods include administering an emulsion that includes zolpidem, a bicarbonate salt, a citrate salt, and a phosphate salt. | 12-10-2015 |
Sathasivan Indiran Pather, El Sobrante, CA US
Patent application number | Description | Published |
---|---|---|
20100240695 | STABILIZED ZOLPIDEM PHARMACEUTICAL COMPOSITIONS - Pharmaceutical compositions for buccal delivery of zolpidem comprising an effective amount of zolpidem and a carbonate and bicarbonate buffer system in an amount sufficient to raise the pH of saliva to at least 8.5, and wherein the carbonate forms a coating on the bicarbonate wherein the amount of carbonate coating is at least 30% (w/w) of the total buffer amount are described. Pharmaceutical compositions for buccal delivery of zolpidem comprising an effective amount of zolpidem and a binary buffer system of carbonate and bicarbonate, wherein the carbonate and bicarbonate are co-located in a single particle, wherein the bicarbonate is coated with the carbonate, and wherein the amount of carbonate coating is at least 30% (w/w) of the binary buffer system are also described. | 09-23-2010 |
20120034300 | STABILIZED ZOLPIDEM PHARMACEUTICAL COMPOSITIONS - Methods of inducing antinociception in a human are described. The method includes the step of administering an effective dose of a polypeptide comprising L-neo-tryptophan to the human extracranially. The polypeptide containing L-neo-tryptophan could be, but is not limited to, NT64L, NT65L, NT66L, NT67L, NT69L, NT69L′, NT71, NT72, NT73, NT74, NT75, NT76, or NT77. | 02-09-2012 |
Sathasivan Indiran Pather US
Patent application number | Description | Published |
---|---|---|
20100249178 | COMPOSITIONS AND METHODS FOR TREATING MIDDLE-OF-THE-NIGHT INSOMNIA - The present invention provides compositions having a therapeutically effective amount of zolpidem, carbonate buffer, bicarbonate buffer, and a mixture comprising large and fine particles of silicon dioxide. Compositions having a therapeutically effective amount of zolpidem, carbonate buffer, bicarbonate buffer, and sodium stearyl fumarate are also described. | 09-30-2010 |
Sathasivan Indiran Pather, Plymouth, MN US
Patent application number | Description | Published |
---|---|---|
20090202632 | Sublingual Buccal Effervescent - A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administerable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of additional pH adjusting substance in combination with the effervescent for promoting the absorption of drugs is also disclosed. | 08-13-2009 |
20110212034 | Sublingual Buccal Effervescent - A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed. | 09-01-2011 |
20110223115 | SUBLINGUAL BUCCAL EFFERVESCENT - A pharmaceutical dosage form adapted to supply a medicament to the oral cavity for buccal, sublingual or gingival absorption of the medicament which contains an orally administrable medicament in combination with an effervescent for use in promoting absorption of the medicament in the oral cavity. The use of an additional pH adjusting substance in combination with the effervescent for promoting the absorption drugs is also disclosed. | 09-15-2011 |
Shyamalan Pather, Seattle, WA US
Patent application number | Description | Published |
---|---|---|
20080263063 | TRANSLATING LATE BOUND LINQ EXPRESSIONS INTO DATABASE QUERIES - There is alteration of a late-bound expression produced by a compiler into an early-bound structure. Alteration of the late-bound expression can occur at runtime and a visitor pattern can be used to create the alteration. In one instance, a conversion from late-bound to early-bound takes place through replacing a late-bound property with a statically typed call. The early-bound structure can translate into an expression tree to enable an implementation of a store specific query operated upon storage. | 10-23-2008 |
20080263078 | RUNTIME CLASS DATABASE OPERATION - Programmers typically like operating with databases through use of classes. Classes allow a user to function with a database through use of a non-database programming language. To ease use of the classes, a class context is generated at runtime that does not force a programmer to handle various source files that are a product of class generation. Therefore, the user can have the ease of using classes without having to perform extra actions. | 10-23-2008 |
20080263531 | AUTOMATIC RUNTIME CONTROL BINDING - Binding can automatically take place between controls and information sources at runtime. This minimizes an amount of code that is to be generated by a user and thus can lower errors from the code. In addition, some wizards that allow binding without code writing can become problematic since some information is not available at runtime (e.g., when the wizard operates prior to runtime.) Relevant information is received and at least one binding is created based off received information. | 10-23-2008 |
20090055364 | DECLARATIVE VIEWS FOR MAPPING - The claimed subject matter provides systems and methods that effectuates and facilitates the generation of bidirectional views. The disclosed system can include components that transform queries and mappings into an internal representation that can be compiled into a bidirectional view. The bidirectional view can thereafter be employed to actuate query and update processing in a relational database management system. | 02-26-2009 |